Fig. 5From: Multimodal image-guided surgery of HER2-positive breast cancer using [111In]In-DTPA-trastuzumab-IRDye800CW in an orthotopic breast tumor modelAfter injection of 10 μg [111In]In-DTPA-trastuzumab-IRDye800CW in a mouse bearing a BT474 tumor, fluorescence imaging identified an additional tumor lesion not identified during resection by white light. After resection of the second tumor, no further fluorescence signal was visibleBack to article page